{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:24:44Z","timestamp":1783178684659,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Abdominal nonfunctional paraganglioma is rare. Malignant potential of paraganglioma is assessed by Grading of Adrenal Pheochromocytoma and Paraganglioma score and genetic testing, but genetic testing is not common. We present a case of abdominal nonfunctional paraganglioma whose malignant potential was assessed by grading of adrenal pheochromocytoma and paraganglioma score and succinate dehydrogenase subunit B staining alternative to genetic testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 39-year-old Japanese man had a right retroperitoneal tumor without symptoms. Uptake in the tumor was shown by <jats:sup>123<\/jats:sup>I-meta-iodobenzylguanidine scintigraphy. There were no metastases. The results of biochemical workups including blood hormones and urinary metanephrines were normal. We performed retroperitoneoscopic surgery. The tumor was positive for chromogranin A staining but negative for tyrosine hydroxylase. On the basis of the preoperative biochemical workups and pathology results, we diagnosed the tumor as nonfunctional paraganglioma. The Grading of Adrenal Pheochromocytoma and Paraganglioma score classified the tumor as moderately differentiated. Furthermore, negative succinate dehydrogenase subunit B staining suggested the patient has the <jats:italic>SDHx<\/jats:italic> (<jats:italic>SDHA<\/jats:italic>, <jats:italic>SDHB<\/jats:italic>, <jats:italic>SDHC<\/jats:italic> and <jats:italic>SDHD<\/jats:italic>) mutation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Abdominal nonfunctional PGLs are associated with <jats:italic>SDHB<\/jats:italic> mutation, and SDHB staining should be performed as a screening.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-03822-3","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:13:20Z","timestamp":1679865200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Abdominal nonfunctional paraganglioma in which succinate dehydrogenase subunit B (SDHB) immunostaining was performed: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-0323","authenticated-orcid":false,"given":"Takazo","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Joraku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Emura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Shikama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Shimazui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"3822_CR1","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2008-1093","volume":"93","author":"HJ Timmers","year":"2008","unstructured":"Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ, Baysal BE, Adams KT, Eisenhofer G. Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J Clin Endocrinol Metab. 2008;93:4826\u201332.","journal-title":"J Clin Endocrinol Metab"},{"key":"3822_CR2","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.210088","volume":"4","author":"EP Lin","year":"2022","unstructured":"Lin EP, Chin BB, Fishbein L, Moritani T, Montoya SP, Ellika S, Newlands S. Head and neck paragangliomas: an update on the molecular classification, state-of-the-art imaging, and management recommendations. Radiol Imaging Cancer. 2022;4: e210088.","journal-title":"Radiol Imaging Cancer"},{"key":"3822_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijscr.2015.11.004","volume":"17","author":"E Gannan","year":"2015","unstructured":"Gannan E, van Veenendaal P, Scarlett A, Ng M. Retroperitoneal non-functioning paraganglioma: a difficult tumour to diagnose and treat. Int J Surg Case Rep. 2015;17:133\u20135.","journal-title":"Int J Surg Case Rep"},{"key":"3822_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/1752-1947-4-216","volume":"4","author":"DF Xu","year":"2010","unstructured":"Xu DF, Chen M, Liu YS, Gao Y, Cui XG. Non-functional paraganglioma of the urinary bladder: a case report. J Med Case Rep. 2010;4:216.","journal-title":"J Med Case Rep"},{"key":"3822_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4103\/0971-3026.155879","volume":"25","author":"P Sherwani","year":"2015","unstructured":"Sherwani P, Anand R, Narula MK, Siddiqui AA, Aggarwal S. Concurrent nonfunctional paraganglioma of the retroperitoneum and urinary bladder: a case report with literature review. Indian J Radiol Imaging. 2015;25:198\u2013201.","journal-title":"Indian J Radiol Imaging"},{"key":"3822_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol. 2022;33:90\u2013114.","journal-title":"Endocr Pathol"},{"key":"3822_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-13-0494","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, et\u00a0al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2014;21:405\u201314.","journal-title":"Endocr Relat Cancer"},{"key":"3822_CR8","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.3390\/cancers13164014","volume":"13","author":"M Yonamine","year":"2021","unstructured":"Yonamine M, Wasano K, Aita Y, Sugasawa T, Takahashi K, Kawakami Y, Shimano H, Nishiyama H, Hara H, Naruse M, et\u00a0al. Prevalence of germline variants in a large cohort of Japanese patients with pheochromocytoma and\/or paraganglioma. Cancers. 2021;13:4014.","journal-title":"Cancers"},{"key":"3822_CR9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","volume":"10","author":"FH van Nederveen","year":"2009","unstructured":"van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EMCA, Sleddens HFBM, Derkx P, Rivi\u00e8re J, Dannenberg H, et\u00a0al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10:764\u201371.","journal-title":"Lancet Oncol"},{"key":"3822_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s11064-015-1738-3","volume":"41","author":"Y Saito","year":"2016","unstructured":"Saito Y, Ishii KA, Aita Y, Ikeda T, Kawakami Y, Shimano H, Hara H, Takekoshi K. Loss of SDHB elevates catecholamine synthesis and secretion depending on ROS production and HIF stabilization. Neurochem Res. 2016;41:696\u2013706.","journal-title":"Neurochem Res"},{"key":"3822_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/EJE-14-0756","volume":"172","author":"M Sue","year":"2015","unstructured":"Sue M, Martucci V, Frey F, Lenders JM, Timmers HJ, Peczkowska M, Prejbisz A, Swantje B, Bornstein SR, Arlt W, et\u00a0al. Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma. Eur J Endocrinol. 2015;172:89\u201395.","journal-title":"Eur J Endocrinol"},{"key":"3822_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF01607135","volume":"421","author":"N Kimura","year":"1992","unstructured":"Kimura N, Miura Y, Nagatsu I, Nagura H. Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol. 1992;421:25\u201332.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"3822_CR13","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/cancers11081070","volume":"11","author":"K Koopman","year":"2019","unstructured":"Koopman K, Gaal J, de Krijger RR. Pheochromocytomas and paragangliomas: new developments with regard to classification, genetics, and cell of origin. Cancers. 2019;11:1070.","journal-title":"Cancers"},{"key":"3822_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.587769","volume":"11","author":"Y Yamazaki","year":"2020","unstructured":"Yamazaki Y, Gao X, Pecori A, Nakamura Y, Tezuka Y, Omata K, Ono Y, Morimoto R, Satoh F, Sasano H. Recent advances in histopathological and molecular diagnosis in pheochromocytoma and paraganglioma: challenges for predicting metastasis in individual patients. Front Endocrinol. 2020;11: 587769.","journal-title":"Front Endocrinol"},{"key":"3822_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00423-018-1679-9","volume":"403","author":"A Stenman","year":"2018","unstructured":"Stenman A, Zedenius J, Juhlin CC. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms. Langenbecks Arch Surg. 2018;403:785\u201390.","journal-title":"Langenbecks Arch Surg"},{"key":"3822_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s12020-020-02332-2","volume":"69","author":"V Amodru","year":"2020","unstructured":"Amodru V, Taieb D, Guerin C, Romanet P, Paladino N, Brue T, Cuny T, Barlier A, Sebag F, Castinetti F. MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives. Endocrine. 2020;69:496\u2013503.","journal-title":"Endocrine"},{"key":"3822_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/ERC-19-0024","volume":"26","author":"J Crona","year":"2019","unstructured":"Crona J, Lamarca A, Ghosal S, Welin S, Skogseid B, Pacak K. Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis. Endocr Relat Cancer. 2019;26:539\u201350.","journal-title":"Endocr Relat Cancer"},{"key":"3822_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101416","volume":"34","author":"A Buffet","year":"2020","unstructured":"Buffet A, Burnichon N, Favier J, Gimenez-Roqueplo AP. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2020;34: 101416.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3822_CR19","doi-asserted-by":"publisher","first-page":"e4661","DOI":"10.1210\/clinem\/dgaa608","volume":"105","author":"H Wachtel","year":"2020","unstructured":"Wachtel H, Hutchens T, Baraban E, Schwartz LE, Montone K, Baloch Z, LiVolsi V, Krumeich L, Fraker DL, Nathanson KL, et\u00a0al. Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems. J Clin Endocrinol Metab. 2020;105:e4661-4670.","journal-title":"J Clin Endocrinol Metab"},{"key":"3822_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187398","volume":"12","author":"JM Koh","year":"2017","unstructured":"Koh JM, Ahn SH, Kim H, Kim BJ, Sung TY, Kim YH, Hong SJ, Song DE, Lee SH. Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma. PLoS ONE. 2017;12: e0187398.","journal-title":"PLoS ONE"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03822-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-03822-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03822-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:14:30Z","timestamp":1679865270000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-03822-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3822"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-03822-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Institutional Ethics Committee with approval number 1043.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}